Venture capital firm's Chinese investment to be reviewed by U.S. Treasury; Small-scale M&A on the rise despite trade tensions, sluggish growth; and U.S. Congressmen urge delisting of 25 Chinese groups from U.S. exchanges.
Jianwei (Jerry) Fang, Xiaoyu (Arthur) Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s Unreliable Entity List, as well as compliance recommendations for multinational corporations
Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications
Jianwei (Jerry) Fang, Chuchen (Julie) Hou and Jiaying (Kate) Jiang of Zhong Lun Law Firm discuss last year’s most significant legislative and judicial developments in civil and commercial dispute resolution in China
Data platforms that look into supply chains benefit from worsening U.S.-China trade relations; China issues first comprehensive guidelines on anti-corruption compliance for the healthcare sector; and complaints have been filed against TikTok, Shein, and AliExpress alleging they are transferring EU personal data to Chinese authorities in violation of GDPR rules.
Chinese cybersecurity regulator details on the lenient certification method for cross-border data transfer; U.S. issues final rule to prevent “adversarial nations” accessing U.S. citizens’ sensitive personal data; and U.S. to ban venture capital funds from backing certain PLA-affiliated companies
Chinese developer sues Apple for removing its app from the App Store; CSRC requires increased shareholder returns to boost stock prices; and Foreigners are choosing to work remotely instead of moving to China
According to the Foreign Investment Law, the Five-Year Transition Period Deadline for FIEs to complete their adjustments pursuant to the law is approaching. Jianwei (Jerry) Fang, Qianwen (Emily) Gu and Chen (Cissy) Chen of Zhong Lun Law Firm analyze the specific requirements of the law and provide practical guidance for FIEs to identify and carry out relevant adjustments.
Revised Chinese Company Law requires mandatory worker representation in boardrooms; Shanghai's biomedical measures catch the most attention; and Merchants of Pinduoduo's international arm, Temu, struggle to sue the company due to its complex structure.
